Related Experiment Video

Updated: Apr 26, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

8.0K

Immunosurveillance markers may predict patients who can discontinue imatinib therapy without relapse

Takayuki Yoshimoto1, Izuru Mizoguchi1, Seiichiro Katagiri2

  • 1Department of Immunoregulation; Institute of Medical Science; Tokyo Medical University; Tokyo, Japan.

Oncoimmunology
|July 25, 2014
PubMed

Keywords:
NK cellschronic myeloid leukemiacytotoxic T lymphocytesimatinibimmunosurvelliancepredictive marker

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

7.7K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.3K

Related Concept Videos